Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McCormack

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
The Australasian Journal of Dermatology|May 20, 2015
Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markersCharlotte Fm Hughes, Kate Newland, Christopher McCormack, et al.
The Australasian Journal of Dermatology|November 20, 2018
Definitive radiotherapy for Merkel cell carcinoma in the setting of epidermolysis bullosa simplexWee Loon Ong, Eliza Bailey, Christopher McCormack, et al.
Leukemia & Lymphoma|October 21, 2003
Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome)Susan J Morgan, H Miles Prince, David A Westerman, et al.
Clinical Case Reports|April 19, 2019
Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patientAnthony D Honigman, Franics Lai, Joshua Elakis, et al.
The Australasian Journal of Dermatology|November 18, 2003
Management of the primary cutaneous lymphomasH Miles Prince, Christopher McCormack, Gail Ryan, et al.
Journal of the American Academy of Dermatology|July 29, 2008
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocolSuzanne Arulogun, H Miles Prince, Peter Gambell, et al.
Leukemia & Lymphoma|July 29, 2022
Unifocal cutaneous blastic plasmacytoid dendritic cell neoplasm with a favorable response following high-dose radiotherapy aloneMartin J Higgins, Sean Harrop, Stephen Lade, et al.
British Journal of Haematology|June 29, 2005
Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T-cell lymphoproliferative disordersSimon D J Gibbs, David A Westerman, Christopher McCormack, et al.
Haematologica|January 26, 2006
Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five casesAshley P Ng, Stephen Lade, Timothy Rutherford, et al.
European Journal of Haematology|November 4, 2004
Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sézary syndromeSimon D J Gibbs, Kirsten E Herbert, Christopher McCormack, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
The Australasian Journal of Dermatology|May 20, 2015
Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markersCharlotte Fm Hughes, Kate Newland, Christopher McCormack, et al.
The Australasian Journal of Dermatology|November 20, 2018
Definitive radiotherapy for Merkel cell carcinoma in the setting of epidermolysis bullosa simplexWee Loon Ong, Eliza Bailey, Christopher McCormack, et al.
Leukemia & Lymphoma|October 21, 2003
Clonal T-helper lymphocytes and elevated IL-5 levels in episodic angioedema and eosinophilia (Gleich's syndrome)Susan J Morgan, H Miles Prince, David A Westerman, et al.
Clinical Case Reports|April 19, 2019
Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patientAnthony D Honigman, Franics Lai, Joshua Elakis, et al.
The Australasian Journal of Dermatology|November 18, 2003
Management of the primary cutaneous lymphomasH Miles Prince, Christopher McCormack, Gail Ryan, et al.
Journal of the American Academy of Dermatology|July 29, 2008
Extracorporeal photopheresis for the treatment of Sézary syndrome using a novel treatment protocolSuzanne Arulogun, H Miles Prince, Peter Gambell, et al.
Leukemia & Lymphoma|July 29, 2022
Unifocal cutaneous blastic plasmacytoid dendritic cell neoplasm with a favorable response following high-dose radiotherapy aloneMartin J Higgins, Sean Harrop, Stephen Lade, et al.
British Journal of Haematology|June 29, 2005
Severe and prolonged myeloid haematopoietic toxicity with myelodysplastic features following alemtuzumab therapy in patients with peripheral T-cell lymphoproliferative disordersSimon D J Gibbs, David A Westerman, Christopher McCormack, et al.
Haematologica|January 26, 2006
Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five casesAshley P Ng, Stephen Lade, Timothy Rutherford, et al.
European Journal of Haematology|November 4, 2004
Alemtuzumab: effective monotherapy for simultaneous B-cell chronic lymphocytic leukaemia and Sézary syndromeSimon D J Gibbs, Kirsten E Herbert, Christopher McCormack, et al.
Pageof 4